Supply Chain Intelligence about:
India
| 日期 | 供应商 | 客户 | 详细信息 | 43 more fields |
|---|---|---|---|---|
| 2025-11-06 | Cipla Ltd. |
Pharmascience Inc.
|
XXXXXXXX XXXXXXXXX XX XXXXX XXXXXXXX XX XXXXXXXX XXXXXXXXXX XXXXXXXX XXXXXXXXXXX XXXXX XX XXXX XXXXXXXXXX XX XXXXXX XXXXX XXXXX XXXX XXXX XXXXX XXXX XXXX XXXXX XXX XX XXXX XXXXX XXXXXXXX XX XXXXXXXX XXXXXXXXXX XXXXXXXX XXXXXXXXXXX XXXXX XX XXXXXXXXXX XX XXXXXX XXXX XXXXX XXXX XXXX XXXXX XXX XX XXXX XXXXX XXXXXXXX XX XXXXXXXX XXXX XXXXXXX XXXXXXXX XX XXXXX XXXXXXX XXXXX XXXX XXXXXXXX XXXXX XXXXXXXX
|
货运提单 |
| 2025-11-04 | Cipla Ltd. |
|
XXX XXXXXXXX X XX XXX XXXXXXXX XX XXXXX XXXX XXXXXX XXXXXX XXXXXXX XXXXX XXXXX XXXXX XXXX X XXXXX XXXXX XXXXXXX XXXXXXXX XXXXX XXXXXXXXXXX XXXXXXXX X XX XXXXXXXXXXXX XXXXXXXXX XXXXXXXXX XXX X X XXXX XX XXX XXXX XXX XXXXXX X XXX XXX XXX XXXX XXX XXXXXX XXXX XX X XXXXX XXX XXXX XXXXXXX XXXX XXXX XXXXX X X XXXXXX XXXXXXX
|
货运提单 |
| 2025-10-28 | Cipla Ltd. |
R.L. Swearer Co. Inc.
|
XXX XXXXXXXX X XX XXX XXXXXXXX XX XXXXX XXXX XXXXXX XXXXXX XXXXXXX XXXXXXXXX X XXXXX XXXX X XXXXX XXXXX XXXXXXX XXXX XXXX XXXXX XXXXXXXXXXX XXXXXXXXX XX XXXXXXXXXXXX XXXXXXXXX XXXXXXXXX XXX XX X XXX XX XXX XXXX XXX XXXXXX XXXX XXX XXXXX XXX XXXX XXXXXXX XXXX XXXX X XXXX X XXXXXXX XXXXXXX
|
货运提单 |
The Indian government has approved imports of Moderna’s SARS-COV-2 vaccine, to be handled by Cipla, as it seeks to tackle the pandemic via both imports and retention of domestically produced vaccines. Cipla’s supply chain activity has already been increasing with Indian imports linked to the f... Read more →
U.S. trade policy is likely to become more rather than less complicated during the fourth quarter, with seven major issues to watch. The passage of the U.S.-Mexico-Canada Agreement may be accelerated as a result of the impeachment process, but in the meantime the U.S. trade deficit with Mexico... Read more →
The latest industry to face President-elect Trump’s attention is pharmaceutical manufacturing, where a commitment has been made to cut costs. While it is not clear how this will be achieved, the U.S. has made significant use of imported generic drugs once branded versions’ patents end. Panjiva... Read more →
U.S. imports of P-PI drugs to manage gastrointestinal disorders climbed 30% in November to reach an all time high, Panjiva data shows. This reflects increased imports of esomeprazole, the generic version of AstraZeneca’s Nexium, which jumped 743% in the past three months on a year earlier. Tha... Read more →
U.S. imports of anticonvulsant drugs (AC), used for epilepsy, migraine and bipolar treatments, climbed 42% in October, the 18th straight increase. This was led by lamotrigine which jumped 150%. Generic drugmakers including Aurobindo Pharma, Cipla and Cadila have taken the lion’s share of the g... Read more →
中文